Scientists have gene-hacked mice to produce their own Ozempic-like enzymes, paving a path for humans to do so themselves one ...

Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.

A one-time gene modification may help the body produce its own 'natural Ozempic,' a study published this week on mice from ...

Japanese researchers have successfully gene-edited mice to produce exenatide, a diabetes drug similar to Ozempic, potentially revolutionizing treatment methods for the disease.

Adults with type 1 diabetes on multiple daily injection therapy saw no benefit in glycemic measures when adding on preprandial injections of short-acting exenatide, according to findings from a ...

Researchers create a one-time genome editing introducing a GLP-1 receptor agonist, resulting in long-term appetite ...

Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18 ...

Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan report a way ...

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...